ArticleThe Journal of pharmacology and experimental therapeutics2017

Novel Pathways of Ponatinib Disposition Catalyzed By CYP1A1 Involving Generation of Potentially Toxic Metabolites.

De Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.